Will genetic therapies revolutionize hearing loss treatment? Dr. Christo Bester, Head of Implant Innovation at Ear Science Institute Australia, discusses the emerging role of gene therapy and personalized medicine in hearing restoration. He highlights the Aussie Earbank initiative, a pioneering effort to collect genetic samples and audiometric data, helping researchers develop targeted treatments. With over 155 genes linked to hearing loss, this presents both challenges and opportunities for targeted interventions. He emphasizes the importance of global collaboration in advancing gene therapy, as large-scale research efforts are needed to bring these treatments from the lab to clinical practice. The discussion sheds light on how biobanking plays a crucial role in identifying patients who may benefit from emerging genetic treatments, offering new hope beyond traditional hearing aids and cochlear implants.Looking ahead, gene therapy and personalized medicine are set to reshape hearing care by complementing existing solutions. While still in its early stages, genetic research is paving the way for a future where treatments are tailored to an individual’s unique genetic profile, potentially restoring hearing function in ways never before possible.Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):

• https://www.linkedin.com/company/this-week-in-hearing/
• https://twitter.com/WeekinHearing